Miho Kato
National Center For Child Health and Development(JP)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Glioma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Childhood Cancer Survivors' Quality of Life, Testicular diseases and treatments
Most-Cited Works
- → Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group(2020)31 cited
- → Transitional dynamics in oncology clinical trials: evaluating the impact of Clinical Trials Act on cooperative groups(2024)3 cited
- → Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma Study Group trials for low-risk embryonal rhabdomyosarcoma(2024)2 cited
- → GCT-15. CLINICAL AND MOLECULAR CHARACTERIZATION OF INFANTILE CENTRAL NERVOUS SYSTEM GERM CELL TUMORS(2024)1 cited
- → Factors associated with survival following relapse of high-risk neuroblastoma: A study from the International Neuroblastoma Risk Group (INRG) Data Commons.(2025)1 cited
- → PEDT-6 A RANDOMIZED CONTROLLED CLINICAL STUDY OF RADIOTHERAPY COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM GERM CELL TUMOR, JCCG CNSGCT2021(2022)1 cited
- → Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post‐Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group(2026)1 cited
- → Pilot study to estimate the safety and effectiveness of hydroxyurea and methotrexate recurrent langerhans cell histiocytosis (LCH-HU-pilot)(2022)1 cited
- → Results of a Phase II Trial for Intermediate‐Risk Rhabdomyosarcoma Treatment Protocol JRS‐I: A Report From the Japan Rhabdomyosarcoma Study Group(2025)
- → Development and validation of the Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) Japanese version.(2022)